| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BFB0050158 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BFb0050158.pdf |
| P698 | PubMed publication ID | 320641 |
| P50 | author | Peter A. Ward | Q65766963 |
| P2093 | author name string | E. L. Becker | |
| P2860 | cites work | Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement | Q28237531 |
| Isolation of an N-acetyl-DL-phenylalanine beta-naphthyl esterase from rabbit peritoneal polymorphonuclear leukocytes | Q28323464 | ||
| The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils | Q28342223 | ||
| Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes | Q28363269 | ||
| Mechanism of eosinophilia. II. Role of the lymphocyte | Q30494909 | ||
| Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes | Q33939897 | ||
| Complement | Q34008595 | ||
| Complement-derived leukotactic factors in inflammatory synovial fluids of humans | Q34058258 | ||
| Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors | Q34462259 | ||
| Antileukotactic properties of tumor cells | Q34481379 | ||
| Chemotactic factor inactivator in normal human serum | Q34504246 | ||
| The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator | Q34511821 | ||
| Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement | Q34739161 | ||
| Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis | Q35092324 | ||
| Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid | Q35900386 | ||
| Characterization of the protease activity in the chemotactic factor inactivator | Q35902491 | ||
| The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly | Q36196127 | ||
| Effects of serotonin, carbamylcholine, and ascorbic acid on leukocyte cyclic GMP and chemotaxis | Q36197638 | ||
| BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS | Q36267397 | ||
| Studies on human leukocyte motility. I. Effects of alterations in pH, electrolyte concentration, and phagocytosis on leukocyte migration, adhesiveness, and aggregation | Q36268270 | ||
| Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes | Q36268461 | ||
| A plasmin-split fragment of C'3 as a new chemotactic factor | Q36268581 | ||
| The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement | Q36268987 | ||
| The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase | Q36269067 | ||
| Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum | Q36269678 | ||
| C3 leukotactic factors produced by a tissue protease | Q36269901 | ||
| In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils | Q36270551 | ||
| An eosinophil leukocyte chemotactic factor of anaphylaxis | Q36270813 | ||
| The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats | Q36270882 | ||
| Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates | Q36271122 | ||
| A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein | Q36271381 | ||
| A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization | Q36272208 | ||
| The selective eosinophil chemotactic activity of histamine | Q36358850 | ||
| Chemotaxis of leucocytes | Q39883984 | ||
| Concanavalin A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice | Q39917301 | ||
| Modulation of human neutrophil chemotactic responses by cyclic 3′,5′-guanosine monophosphate and cyclic 3′,5′-adenosine monophosphate | Q39929248 | ||
| Effect of Exogenous Cyclic AMP and other Adenine Nucleotides on Neutrophil Chemotaxis and Motility | Q39957298 | ||
| Protein kinase and phosphatases from human polymorphonuclear leucoytes | Q40336909 | ||
| The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes | Q41514223 | ||
| Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator | Q42836210 | ||
| Leucocyte locomotion and chemotaxis. The influence of divalent cations and cation ionophores | Q43726216 | ||
| Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells | Q43755779 | ||
| Leukotactic dystunction in sarcoidosis | Q44257076 | ||
| Studies on the relation between the fifth component of complement and anaphylatoxinogen | Q44509929 | ||
| Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator | Q44580304 | ||
| Chemistry and biology of the anaphylatoxin related serum peptide system. III. Evaluation of leucotactic activity as a property of a new peptide system with classical anaphylatoxin and cocytotaxin as components | Q44907443 | ||
| Leukotactic Factor Produced by Sensitized Lymphocytes | Q46429354 | ||
| The difference between random movement and chemotaxis. Effects of antitubulins on neutrophil granulocyte locomotion. | Q53993543 | ||
| Surface and cell membrane activities of leukocyte chemotactic factors. | Q54171493 | ||
| Neutrophil Actin Dysfunction and Abnormal Neutrophil Behavior | Q54469619 | ||
| Tumor-associated eosinophilotactic factor. | Q54498215 | ||
| Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes | Q59053930 | ||
| Cyclic GMP and Cell Movement | Q59095122 | ||
| Inhibition of leukocyte locomotion and chemotaxis by lipid-specific bacterial toxins | Q66941140 | ||
| Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation | Q67289697 | ||
| The chemotactic activity of fibrin lysis products | Q68507863 | ||
| Retraction fibers and leucocyte chemotaxis | Q68685639 | ||
| Chemotaxis of polymorphonuclear leukocytes | Q68726756 | ||
| Locomotion of human polymorphonuclear leucocytes | Q69183594 | ||
| Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls | Q69374230 | ||
| Biologic activity of extracts of delayed hypersensitivity skin reaction sites | Q70004096 | ||
| In vitro studies of immunologically induced secretion of mediators from cells and related phenomena | Q70011112 | ||
| Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis | Q70439654 | ||
| Altered movement of endosomes in colchicine-treated cultured macrophages | Q71755365 | ||
| Chemotaxis of Polymorphonuclear Leukocytes from Patients with Diabetes Mellitus | Q71762174 | ||
| Leukocyte motility. II. Effect of absence of glucose in medium; effect of presence of deoxyglucose, dinitrophenol, puromycin, actinomycin D, and trypsin on the response to chemotactic substance; effect of segregation of cells from chemotactic substa | Q72257673 | ||
| Crystal-Induced Arthritis | Q72337227 | ||
| Colchicine inhibition of chemotaxis | Q72637988 | ||
| Leukocyte motility. I. Method of study, normal variation, effect of physical alterations in environment, and effect of iodoacetate | Q72788022 | ||
| Leucocyte locomotion and its inhibition by antimitotic drugs | Q93753452 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukocyte chemotaxis | Q14864444 |
| P304 | page(s) | 125-148 | |
| P577 | publication date | 1977-01-01 | |
| P1433 | published in | Reviews of Physiology, Biochemistry and Pharmacology | Q15760415 |
| P1476 | title | Biology of leukotaxis | |
| P478 | volume | 77 |
| Q42735459 | A study of the origin of pulmonary macrophages using the Chédiak-Higashi marker |
| Q37328574 | Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5 |
| Q66925140 | Chemotactic factor inactivator release from rat leukocytes |
| Q41033231 | Effect of cytochalasin B on human neutrophil aggregation |
| Q28397007 | Immunopathology of the lung: a review |
| Q40298683 | Inflammatory proteins: chemical and biological aspects |
| Q67017748 | Isolation by hydrophobic chromatography of the chemotactic factor inactivators from human serum |
| Q41561333 | Mechanisms of Leukocyte Regulation by Complement-Derived Factors |
| Q50942643 | Modulation of human polymorphonuclear leukocyte chemotaxis by leukocyte extracts, bacterial products, inflammatory exudates, and polyelectrolytes. |
| Q39248177 | Neutrophil function and host resistance |
| Q39830342 | Phagocyte Chemotaxis |
Search more.